{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:05:00Z","timestamp":1771657500286,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangxi Bagui Scholar"},{"name":"Guangxi Medical University Training Program for Distinguished Young Scholars"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Vaccination has been proven to be an effective approach against the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine the acceptance rate and factors influencing acceptance of COVID-19 vaccination among people living with HIV (PLWH) in Guangxi, China.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional survey was carried out in five cities in Guangxi, China from May 7 to June 1, 2021. Questionnaires on the acceptance of COVID-19 vaccination and the related factors were conducted among PLWH recruited by simple random sampling. Univariate and multivariate logistic regression analyses were performed to identify factors associated with acceptance of COVID-19 vaccination.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of all valid respondents (<jats:italic>n<\/jats:italic>\u2009=\u2009903), 72.9% (<jats:italic>n<\/jats:italic>\u2009=\u2009658) were willing to receive COVID-19 vaccination. Fear of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was the main reason for being willing to receive vaccination (76.0%), while the main reasons for not willing were the concerns about vaccine safety (54.7%) and the vaccination\u2019s effect on antiretroviral therapy (ART) (50.6%). The most important factors influencing acceptance were the perception that vaccination is unsafe for HIV-infected people (aOR\u2009=\u20090.082, 95% CI\u2009=\u20090.024\u20130.282) and the poor efficacy in preventing SARS-CoV-2 infection in HIV-infected people (aOR\u2009=\u20090.093, 95% CI\u2009=\u20090.030\u20130.287). Other factors associated with acceptance included Zhuang ethnicity (aOR\u2009=\u20091.653, 95% CI\u2009=\u20091.109\u20132.465), highest education level of middle school, high school or above (aOR\u2009=\u20091.747, 95% CI\u2009=\u20091.170\u20132.608; aOR\u2009=\u20092.492, 95% CI\u2009=\u20091.326\u20134.682), and the vaccination having little effect on ART efficacy (aOR\u2009=\u20092.889, 95% CI\u2009=\u20091.378<jats:italic>\u2013<\/jats:italic>6.059).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Acceptance rate of the COVID-19 vaccination is relatively low among PLWH compared to the general population in China, although some patients refused vaccination due to concerns about vaccine safety and vaccination affecting ART efficacy. More research is needed to investigate the impact of the COVID-19 vaccines on ART efficacy and the effectiveness in preventing SARS-CoV-2 infection among PLWH.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-022-07452-w","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T12:03:12Z","timestamp":1652702592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey"],"prefix":"10.1186","volume":"22","author":[{"given":"Jinming","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengxiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunlin","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongxue","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinlu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjuan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanyan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"7452_CR1","unstructured":"WHO Coronavirus (COVID-19). 2021. https:\/\/covid19.who.int\/. Accessed 30 Apr 2022."},{"issue":"1","key":"7452_CR2","doi-asserted-by":"publisher","first-page":"4887","DOI":"10.1038\/s41467-021-25153-x","volume":"12","author":"S Zhao","year":"2021","unstructured":"Zhao S, Zhang H, Yang X, Zhang H, Chen Y, Zhan Y, Zhang X, Jiang R, Liu M, Liu L, et al. Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics. Nat Commun. 2021;12(1):4887.","journal-title":"Nat Commun"},{"issue":"37","key":"7452_CR3","doi-asserted-by":"publisher","first-page":"5285","DOI":"10.1016\/j.vaccine.2021.07.081","volume":"39","author":"J Feng","year":"2021","unstructured":"Feng J, Li Q. How to ensure vaccine safety: an evaluation of China\u2019s vaccine regulation system. Vaccine. 2021;39(37):5285\u201394.","journal-title":"Vaccine"},{"issue":"1","key":"7452_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1186\/s13063-020-04775-4","volume":"21","author":"R Palacios","year":"2020","unstructured":"Palacios R, Patino EG, de Oliveira PR, Conde M, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF, et al. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac\u2014PROFISCOV: a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):853.","journal-title":"Trials"},{"issue":"10","key":"7452_CR5","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1016\/j.jaip.2021.07.016","volume":"9","author":"KL Flanagan","year":"2021","unstructured":"Flanagan KL, MacIntyre CR, McIntyre PB, Nelson MR. SARS-CoV-2 vaccines: where are we now? J Allergy Clin Immunol Pract. 2021;9(10):3535\u201343.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"8","key":"7452_CR6","first-page":"979","volume":"2","author":"C Pawlowski","year":"2021","unstructured":"Pawlowski C, Lenehan P, Puranik A, Agarwal V, Venkatakrishnan AJ, Niesen MJM, O\u2019Horo JC, Virk A, Swift MD, Badley AD, et al. FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. Med (NY). 2021;2(8):979-992e978.","journal-title":"Med (NY)"},{"issue":"10229","key":"7452_CR7","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"2","key":"7452_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1055\/a-1552-4449","volume":"130","author":"I Sahin","year":"2022","unstructured":"Sahin I, Haymana C, Demir T, Demirci I, Tasci I, Atmaca A, Cakal E, Ata N, Emral R, Unluturk U, et al. Clinical characteristics and outcomes of COVID-19 patients with overweight and obesity: Turkish Nationwide Cohort Study (TurCObesity). Exp Clin Endocrinol Diabetes. 2022;130(2):115\u201324.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"7452_CR9","unstructured":"UNAIDS. Confronting Inequalities\u20142021 Global AIDS Update. 2021. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2021-global-aids-update_en.pdf. Accessed 14 Jul 2021."},{"key":"7452_CR10","unstructured":"Disease Prevention and Control Administration of National Health Commission of the People\u2019s Republic of China: New progress in the prevention and treatment of AIDS in China in 2019. Chin J AIDS STD. 2019;25(12):1205."},{"issue":"3","key":"7452_CR11","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/infdis\/jiaa380","volume":"223","author":"HE Ho","year":"2021","unstructured":"Ho HE, Peluso MJ, Margus C, Matias Lopes JP, He C, Gaisa MM, Osorio G, Aberg JA, Mullen MP. Clinical outcomes and immunologic characteristics of coronavirus disease 2019 in people with human immunodeficiency virus. J Infect Dis. 2021;223(3):403\u20138.","journal-title":"J Infect Dis"},{"issue":"12","key":"7452_CR12","doi-asserted-by":"publisher","first-page":"e1021","DOI":"10.1093\/cid\/ciaa1793","volume":"72","author":"SL Braunstein","year":"2021","unstructured":"Braunstein SL, Lazar R, Wahnich A, Daskalakis DC, Blackstock OJ. Coronavirus disease 2019 (COVID-19) infection among people with human immunodeficiency virus in New York City: a population-level analysis of linked surveillance data. Clin Infect Dis. 2021;72(12):e1021\u20139.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"7452_CR13","doi-asserted-by":"publisher","first-page":"e554","DOI":"10.1016\/S2352-3018(21)00151-X","volume":"8","author":"W Jassat","year":"2021","unstructured":"Jassat W, Cohen C, Tempia S, Masha M, Goldstein S, Kufa T, Murangandi P, Savulescu D, Walaza S, Bam JL, et al. Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study. Lancet HIV. 2021;8(9):e554\u201367.","journal-title":"Lancet HIV"},{"issue":"1","key":"7452_CR14","doi-asserted-by":"publisher","first-page":"6283","DOI":"10.1038\/s41598-021-85359-3","volume":"11","author":"P Ssentongo","year":"2021","unstructured":"Ssentongo P, Heilbrunn ES, Ssentongo AE, Advani S, Chinchilli VM, Nunez JJ, Du P. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis. Sci Rep. 2021;11(1):6283.","journal-title":"Sci Rep"},{"key":"7452_CR15","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ijid.2019.02.016","volume":"81","author":"YC Qiao","year":"2019","unstructured":"Qiao YC, Xu Y, Jiang DX, Wang X, Wang F, Yang J, Wei YS. Epidemiological analyses of regional and age differences of HIV\/AIDS prevalence in China, 2004\u20132016. Int J Infect Dis. 2019;81:215\u201320.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"7452_CR16","first-page":"45","volume":"30","author":"XP Dong Pengyu","year":"2017","unstructured":"Dong Pengyu XP, Xiaoqiang L, Hong L, Guozhong H. Analysis of epidemic and prevention situation of major infectious diseases in China\u2019s Southwest Border Area. Med Soc. 2017;30(2):45\u20138.","journal-title":"Med Soc"},{"issue":"3","key":"7452_CR17","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3390\/vaccines8030482","volume":"8","author":"J Wang","year":"2020","unstructured":"Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines (Basel). 2020;8(3):482.","journal-title":"Vaccines (Basel)"},{"issue":"12","key":"7452_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008961","volume":"14","author":"Y Lin","year":"2020","unstructured":"Lin Y, Hu Z, Zhao Q, Alias H, Danaee M, Wong LP. Understanding COVID-19 vaccine demand and hesitancy: a nationwide online survey in China. PLoS Negl Trop Dis. 2020;14(12): e0008961.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"7452_CR19","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","volume":"27","author":"JV Lazarus","year":"2021","unstructured":"Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225\u20138.","journal-title":"Nat Med"},{"issue":"2","key":"7452_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37069","volume":"4","author":"JM Tesoriero","year":"2021","unstructured":"Tesoriero JM, Swain CE, Pierce JL, Zamboni L, Wu M, Holtgrave DR, Gonzalez CJ, Udo T, Morne JE, Hart-Malloy R, et al. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open. 2021;4(2): e2037069.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"7452_CR21","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(20)30211-3","volume":"7","author":"BL Jewell","year":"2020","unstructured":"Jewell BL, Mudimu E, Stover J, Ten Brink D, Phillips AN, Smith JA, Martin-Hughes R, Teng Y, Glaubius R, Mahiane SG, et al. Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models. Lancet HIV. 2020;7(9):e629\u201340.","journal-title":"Lancet HIV"},{"key":"7452_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.741862","volume":"9","author":"D Chilot","year":"2022","unstructured":"Chilot D, Woldeamanuel Y, Manyazewal T. COVID-19 burden on HIV patients attending antiretroviral therapy in Addis Ababa, Ethiopia: a multicenter cross-sectional study. Front Med (Lausanne). 2022;9: 741862.","journal-title":"Front Med (Lausanne)"},{"key":"7452_CR23","unstructured":"WHO. The cost of inaction: COVID-19-related service disruptions could cause hundreds of thousands of extra deaths from HIV. 2020. https:\/\/www.who.int\/news\/item\/11-05-2020-the-cost-of-inaction-covid-19-related-service-disruptions-could-cause-hundreds-of-thousands-of-extra-deaths-from-hiv. Accessed 2 Jun 2020."},{"issue":"29","key":"7452_CR24","doi-asserted-by":"publisher","first-page":"3952","DOI":"10.1016\/j.vaccine.2021.05.058","volume":"39","author":"T Yang","year":"2021","unstructured":"Yang T, Liu B, Yue L, Xie T, Li H, Shao M, Yang R, Luo F, Long R, Xie Z. Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71. Vaccine. 2021;39(29):3952\u201363.","journal-title":"Vaccine"},{"issue":"7","key":"7452_CR25","doi-asserted-by":"publisher","first-page":"e940","DOI":"10.1016\/S2214-109X(19)30079-8","volume":"7","author":"WM Sullender","year":"2019","unstructured":"Sullender WM, Fowler KB, Gupta V, Krishnan A, Ram Purakayastha D, Srungaram Vln R, Lafond KE, Saha S, Palomeque FS, Gargiullo P, et al. Efficacy of inactivated trivalent influenza vaccine in rural India: a 3-year cluster-randomised controlled trial. Lancet Glob Health. 2019;7(7):e940\u201350.","journal-title":"Lancet Glob Health"},{"issue":"10","key":"7452_CR26","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1056\/NEJMoa2107715","volume":"385","author":"A Jara","year":"2021","unstructured":"Jara A, Undurraga EA, Gonzalez C, Paredes F, Fontecilla T, Jara G, Pizarro A, Acevedo J, Leo K, Leon F, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875\u201384.","journal-title":"N Engl J Med"},{"issue":"4","key":"7452_CR27","doi-asserted-by":"publisher","first-page":"taab026","DOI":"10.1093\/jtm\/taab026","volume":"28","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen S. What can we learn from COVID-19 vaccine R&D in China? A discussion from a public policy perspective. J Travel Med. 2021;28(4):taab026.","journal-title":"J Travel Med"},{"issue":"17","key":"7452_CR28","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.vaccine.2021.08.007","volume":"40","author":"RH Dodd","year":"2022","unstructured":"Dodd RH, Pickles K, Cvejic E, Cornell S, Isautier JMJ, Copp T, Nickel B, Bonner C, Batcup C, Muscat DM, et al. Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia. Vaccine. 2022;40(17):2484\u201390.","journal-title":"Vaccine"},{"key":"7452_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyg.2021.694151","volume":"12","author":"SR Acharya","year":"2021","unstructured":"Acharya SR, Moon DH, Shin YC. Assessing attitude toward COVID-19 vaccination in South Korea. Front Psychol. 2021;12: 694151.","journal-title":"Front Psychol"},{"issue":"15","key":"7452_CR30","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","volume":"384","author":"N Dagan","year":"2021","unstructured":"Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernan MA, Lipsitch M, Reis B, Balicer RD. BNT162b2 mRNA COVID-19 vaccine in a nationwide mass vaccination setting. N Engl J Med. 2021;384(15):1412\u201323.","journal-title":"N Engl J Med"},{"key":"7452_CR31","unstructured":"WHO. The-race-for-a-covid-19-vaccine-explained 2021. https:\/\/www.who.int\/zh\/news-room\/feature-stories\/detail\/the-race-for-a-covid-19-vaccine-explained. Accessed 12 Jan 2021."},{"issue":"2","key":"7452_CR32","first-page":"205","volume":"31","author":"LY Zheng","year":"2018","unstructured":"Zheng LY, Chun-yang LI. Application and progress in research of live attenuated vaccines. Chin J Biolog. 2018;31(2):205\u20138.","journal-title":"Chin J Biolog"},{"issue":"9","key":"7452_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2021.101169","volume":"67","author":"M Shekatkar","year":"2021","unstructured":"Shekatkar M, Kheur S, Gupta AA, Arora A, Raj AT, Patil S, Khan SS, Desai A, Carroll WB, Awan KH. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy. Dis Mon. 2021;67(9): 101169.","journal-title":"Dis Mon"},{"issue":"7","key":"7452_CR34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.7326\/M20-3689","volume":"173","author":"J del Amo","year":"2020","unstructured":"del Amo J, Polo R, Moreno S, Diaz A, Martinez E, Arribas JR, Jarrin I, Hernan MA. Collaboration SHC-: incidence and severity of COVID-19 in HIV-positive persons receiving antiretroviral therapy a cohort study. Ann Intern Med. 2020;173(7):536\u201341.","journal-title":"Ann Intern Med"},{"key":"7452_CR35","unstructured":"Western Cape Department of Health in collaboration with the National Institute for Communicable Diseases, South Africa: Risk factors for COVID-19 death in a population cohort study from the Western Cape Province, South Africa. Clin Infect Dis. 2021;73(7):e2005\u2013e2015."},{"issue":"13","key":"7452_CR36","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1097\/QAD.0000000000002663","volume":"34","author":"A Di Biagio","year":"2020","unstructured":"Di Biagio A, Ricci E, Calza L, Squillace N, Menzaghi B, Rusconi S, Orofino G, Bargiacchi O, Molteni C, Valsecchi L, et al. Factors associated with hospital admission for COVID-19 in HIV patients. AIDS. 2020;34(13):1983\u20135.","journal-title":"AIDS"},{"issue":"12","key":"7452_CR37","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1097\/QAD.0000000000002643","volume":"34","author":"A Inciarte","year":"2020","unstructured":"Inciarte A, Gonzalez-Cordon A, Rojas J, Torres B, de Lazzari E, de la Mora L, Martinez-Rebollar M, Laguno M, Callau P, Gonzalez-Navarro A, et al. Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study. AIDS. 2020;34(12):1775\u201380.","journal-title":"AIDS"},{"key":"7452_CR38","unstructured":"HIV\/AIDS and hepatitis C Group, Society of Infectious Diseases, CMA: Expert recommendation for novel severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) vaccination in patients with HIV infection. Chin J Intern Med. 2021;60(7):615\u2013618."},{"issue":"10","key":"7452_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1080\/10810730.2020.1868630","volume":"25","author":"JV Lazarus","year":"2020","unstructured":"Lazarus JV, Wyka K, Rauh L, Rabin K, Ratzan S, Gostin LO, Larson HJ, El-Mohandes A. Hesitant or Not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: a country-level analysis. J Health Commun. 2020;25(10):799\u2013807.","journal-title":"J Health Commun"},{"issue":"1","key":"7452_CR40","first-page":"70","volume":"40","author":"XJ Zhou","year":"2019","unstructured":"Zhou XJ, Zhu QY, Li JJ, Lan GH, Liang SS, Liu SF, Liu XH, Meng Q, Zhou CX, Shen ZY. Characteristics of HIV-infected persons without long term disease progress and related factors in Guangxi Zhuang Autonomous Region. Zhonghua Liu Xing Bing Xue Za Zhi. 2019;40(1):70\u20133.","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"30","key":"7452_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.46234\/ccdcw2021.147","volume":"3","author":"N Kang","year":"2021","unstructured":"Kang N, Liu Y, Bi F, Wang J, Chen H, Wang J, Liang Z, Chen M, Wei G, Li A, et al. Detection of Variants of B.1.617 lineage from five returning Chinese Nationals at a Guangxi-Vietnam Border Port\u2014Guangxi Zhuang Autonomous Region, China, April 2021. China CDC Wkly. 2021;3(30):653\u20135.","journal-title":"China CDC Wkly"},{"issue":"10225","key":"7452_CR42","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S0140-6736(20)30260-9","volume":"395","author":"JT Wu","year":"2020","unstructured":"Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020;395(10225):689\u201397.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07452-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-022-07452-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-022-07452-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T12:03:57Z","timestamp":1652702637000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-022-07452-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["7452"],"URL":"https:\/\/doi.org\/10.1186\/s12879-022-07452-w","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"assertion":[{"value":"24 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics and Human Subjects Committee (EHSC) of Guangxi Medical University [No. 20210153]. All participants were verbally informed of the purpose of the study and signed the informed consent forms. All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"471"}}